Clinical Trials Browser

OTHER × Neoplasms, Plasma Cell × Vincristine × Clear all

NCT00054158 2022-10-03

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Phase 2 Completed

Multiple Myeloma, Neoplasms, Plasma Cell